 BOSTON, April 19, 2021 PRNewswire -- Haemonetics Corporation NYSE: HAE Haemonetics or the Company, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that CSL Plasma, Ltd. CSL has informed Haemonetics of its intent not to renew its Supply Agreement with Haemonetics for the use of PCS2 Plasma Collection System devices and the purchase of disposable plasmapheresis kits in the U.S. following the expiration of the current term in June 2022. 